[Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].

Astaf'ev, A V; Styrt, E A; Sinopal'nikov, A I

Astaf'ev, A V; Styrt, E A; Sinopal'nikov, A I.

Klin Med (Mosk) ; 91(3): 44-50, 2013.

Article in Ru | MEDLINE | ID: mdl-23789452

Subject(s)

Amoxicillin-Potassium Clavulanate Combination/administration & dosage; Anti-Bacterial Agents/administration & dosage; Levofloxacin; Ofloxacin/administration & dosage; Pulmonary Disease, Chronic Obstructive/drug therapy; Aged; Amoxicillin-Potassium Clavulanate Combination/adverse effects; Amoxicillin-Potassium Clavulanate Combination/economics; Amoxicillin-Potassium Clavulanate Combination/pharmacology; Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/economics; Anti-Bacterial Agents/pharmacology; Female; Humans; Male; Middle Aged; Ofloxacin/adverse effects; Ofloxacin/economics; Ofloxacin/pharmacology; Pulmonary Disease, Chronic Obstructive/microbiology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Ofloxacin / Amoxicillin-Potassium Clavulanate Combination / Pulmonary Disease, Chronic Obstructive / Levofloxacin / Anti-Bacterial Agents Type of study: Clinical_trials Language: Ru Journal: Klin Med (Mosk) Year: 2013 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links